EPS创健科技(03860)发盈喜,预期年度溢利约3000万港元 同比扭亏为盈

智通财经
Jun 12, 2025

智通财经APP讯,EPS创健科技(03860)发布公告,本集团预期于截至2025年3月31日止年度将录得溢利约3000万港元,而截至2024年3月31日止年度则录得亏损2650万港元。溢利增加主要由于本集团于2025年3月完成出售于直接全资附属公司EPS Innovative Medicine (Hong Kong) Limited全部已发行股本的所得收益。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10